A Study of ONO-7429 in Participants With Unresectable Advanced or Recurrent Solid Tumors

Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors

NCT03182257 ·Status: TERMINATED ·Phase: PHASE1

Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

NCT03155061 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors

NCT01546428 ·Status: COMPLETED ·Phase: PHASE1

An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

NCT00280397 ·Status: COMPLETED ·Phase: PHASE1

ONO-4538 Phase I Study in Patients With Solid Tumor

NCT02261298 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors

NCT07077434 ·Status: RECRUITING ·Phase: PHASE1

A Phase I Study of BR790 in Subjects With Advanced Solid Tumors

NCT04891653 ·Status: UNKNOWN ·Phase: PHASE1

ONO-4538 Phase I Study in Patients With Solid Tumor

NCT02261285 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

NCT00412789 ·Status: COMPLETED ·Phase: PHASE1

To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550

NCT04674748 ·Status: TERMINATED ·Phase: PHASE1

Study of DS-1123a in Advanced Solid Tumours

NCT02690337 ·Status: COMPLETED ·Phase: PHASE1

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

NCT01610479 ·Status: COMPLETED ·Phase: PHASE1

First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid Tumors

NCT01881217 ·Status: COMPLETED ·Phase: PHASE1

Dose Escalation Study of SH U04722 in Solid Tumors

NCT00375453 ·Status: TERMINATED ·Phase: PHASE1

A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

NCT01293630 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Safety And Tolerability, Solid Tumor

NCT00768469 ·Status: COMPLETED ·Phase: PHASE1

Study of FCN-098 in Patients With Advanced Solid Tumor

NCT05212987 ·Status: UNKNOWN ·Phase: PHASE1

Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors

NCT00877474 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06307795 ·Status: RECRUITING ·Phase: PHASE1

A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors

NCT06548217 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors

NCT00516451 ·Status: COMPLETED ·Phase: PHASE1

A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors

NCT00397046 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan

NCT00503477 ·Status: COMPLETED ·Phase: PHASE1

A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.

NCT07734116 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study of DM005 in Patients With Advanced Solid Tumors

NCT06515990 ·Status: RECRUITING ·Phase: PHASE1/PHASE2